Keratoprostheses in the Setting of Autoimmune Disorders

Matthew J. Weiss, Victor L Perez Quinones

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Many clinical conditions exist in which standard penetrating keratoplasties are at high risk of failure. These situations require alternative interventions including keratoprostheses. The most challenging of this subset of patients to treat are those with corneal blindness due to autoimmune diseases. Studies have suggested that these patients respond poorly to transplantation due to alterations in corneal tissue at the level of the cellular, microbiological, and immunological microenvironments due to the inflammatory nature of autoimmune-related conjunctivitides. A variety of interventions exist for visual rehabilitation in this patient population depending on the severity of the condition. These options range from artificial keratoprostheses, such as the Boston keratoprosthesis type 1 in patients with a lubricated ocular surface, to the biologic keratoprostheses like the modified osteo-odonto keratoprosthesis (MOOKP) in the most severe autoimmune patients. The current literature suggests that in the setting of autoimmune dysfunction, biological keratoprostheses are far superior to their artificial keratoprosthesis alternatives.

Original languageEnglish (US)
Title of host publicationKeratoprostheses and Artificial Corneas: Fundamentals and Surgical Applications
PublisherSpringer Berlin Heidelberg
Pages137-144
Number of pages8
ISBN (Print)9783642551796, 9783642551789
DOIs
StatePublished - Jan 1 2015

Fingerprint

Penetrating Keratoplasty
Blindness
Autoimmune Diseases
Rehabilitation
Transplantation
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Weiss, M. J., & Perez Quinones, V. L. (2015). Keratoprostheses in the Setting of Autoimmune Disorders. In Keratoprostheses and Artificial Corneas: Fundamentals and Surgical Applications (pp. 137-144). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-55179-6_16

Keratoprostheses in the Setting of Autoimmune Disorders. / Weiss, Matthew J.; Perez Quinones, Victor L.

Keratoprostheses and Artificial Corneas: Fundamentals and Surgical Applications. Springer Berlin Heidelberg, 2015. p. 137-144.

Research output: Chapter in Book/Report/Conference proceedingChapter

Weiss, MJ & Perez Quinones, VL 2015, Keratoprostheses in the Setting of Autoimmune Disorders. in Keratoprostheses and Artificial Corneas: Fundamentals and Surgical Applications. Springer Berlin Heidelberg, pp. 137-144. https://doi.org/10.1007/978-3-642-55179-6_16
Weiss MJ, Perez Quinones VL. Keratoprostheses in the Setting of Autoimmune Disorders. In Keratoprostheses and Artificial Corneas: Fundamentals and Surgical Applications. Springer Berlin Heidelberg. 2015. p. 137-144 https://doi.org/10.1007/978-3-642-55179-6_16
Weiss, Matthew J. ; Perez Quinones, Victor L. / Keratoprostheses in the Setting of Autoimmune Disorders. Keratoprostheses and Artificial Corneas: Fundamentals and Surgical Applications. Springer Berlin Heidelberg, 2015. pp. 137-144
@inbook{398869053fa84d279b37f7c45c1998a7,
title = "Keratoprostheses in the Setting of Autoimmune Disorders",
abstract = "Many clinical conditions exist in which standard penetrating keratoplasties are at high risk of failure. These situations require alternative interventions including keratoprostheses. The most challenging of this subset of patients to treat are those with corneal blindness due to autoimmune diseases. Studies have suggested that these patients respond poorly to transplantation due to alterations in corneal tissue at the level of the cellular, microbiological, and immunological microenvironments due to the inflammatory nature of autoimmune-related conjunctivitides. A variety of interventions exist for visual rehabilitation in this patient population depending on the severity of the condition. These options range from artificial keratoprostheses, such as the Boston keratoprosthesis type 1 in patients with a lubricated ocular surface, to the biologic keratoprostheses like the modified osteo-odonto keratoprosthesis (MOOKP) in the most severe autoimmune patients. The current literature suggests that in the setting of autoimmune dysfunction, biological keratoprostheses are far superior to their artificial keratoprosthesis alternatives.",
author = "Weiss, {Matthew J.} and {Perez Quinones}, {Victor L}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-642-55179-6_16",
language = "English (US)",
isbn = "9783642551796",
pages = "137--144",
booktitle = "Keratoprostheses and Artificial Corneas: Fundamentals and Surgical Applications",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Keratoprostheses in the Setting of Autoimmune Disorders

AU - Weiss, Matthew J.

AU - Perez Quinones, Victor L

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Many clinical conditions exist in which standard penetrating keratoplasties are at high risk of failure. These situations require alternative interventions including keratoprostheses. The most challenging of this subset of patients to treat are those with corneal blindness due to autoimmune diseases. Studies have suggested that these patients respond poorly to transplantation due to alterations in corneal tissue at the level of the cellular, microbiological, and immunological microenvironments due to the inflammatory nature of autoimmune-related conjunctivitides. A variety of interventions exist for visual rehabilitation in this patient population depending on the severity of the condition. These options range from artificial keratoprostheses, such as the Boston keratoprosthesis type 1 in patients with a lubricated ocular surface, to the biologic keratoprostheses like the modified osteo-odonto keratoprosthesis (MOOKP) in the most severe autoimmune patients. The current literature suggests that in the setting of autoimmune dysfunction, biological keratoprostheses are far superior to their artificial keratoprosthesis alternatives.

AB - Many clinical conditions exist in which standard penetrating keratoplasties are at high risk of failure. These situations require alternative interventions including keratoprostheses. The most challenging of this subset of patients to treat are those with corneal blindness due to autoimmune diseases. Studies have suggested that these patients respond poorly to transplantation due to alterations in corneal tissue at the level of the cellular, microbiological, and immunological microenvironments due to the inflammatory nature of autoimmune-related conjunctivitides. A variety of interventions exist for visual rehabilitation in this patient population depending on the severity of the condition. These options range from artificial keratoprostheses, such as the Boston keratoprosthesis type 1 in patients with a lubricated ocular surface, to the biologic keratoprostheses like the modified osteo-odonto keratoprosthesis (MOOKP) in the most severe autoimmune patients. The current literature suggests that in the setting of autoimmune dysfunction, biological keratoprostheses are far superior to their artificial keratoprosthesis alternatives.

UR - http://www.scopus.com/inward/record.url?scp=84943338746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943338746&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-55179-6_16

DO - 10.1007/978-3-642-55179-6_16

M3 - Chapter

SN - 9783642551796

SN - 9783642551789

SP - 137

EP - 144

BT - Keratoprostheses and Artificial Corneas: Fundamentals and Surgical Applications

PB - Springer Berlin Heidelberg

ER -